Women's Health News and Research

RSS

Mediterranean-style diet during pregnancy lowers risk of infant colic and eczema

Infants born to mothers who ate a healthy, Mediterranean-style diet during pregnancy were at lower risk for colic and eczema, according to a new study by researchers at Harvard T.H. Chan School of Public Health, Boston Children's Hospital, and Harvard Pilgrim Health Care Institute.

12 Oct 2026

Extreme heat threatens maternal health and newborn wellbeing worldwide

Extreme heat has led to a marked increase in the risks faced by pregnant women and their babies, according to a survey of 1,000 healthcare professionals in countries including Brazil, India and Zimbabwe.

11 Oct 2026

Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer

Alliance Foundation Trials, LLC (AFT), a national leader in conducting innovative, practice-changing cancer clinical trials, and Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the launch of AFT-70 NAVIGATE, a randomized phase III trial evaluating a novel molecular residual disease (MRD)-guided treatment strategy for patients with intermediate and high-risk ER-positive/HER2-negative early breast cancer.

5 Oct 2026

Patient navigators significantly improve postpartum care for low-income mothers

While the transition to motherhood can be challenging for anyone, barriers such as inadequate health literacy, unreliable transportation, navigating a complex health care system, limited access to childcare or insecure housing can be the tipping point between a new mom accessing needed care or going without it.

5 Oct 2026

Ultrasensitive AMH testing offers new insights into midlife ovarian reserve

In women's lifelong health management, the years from 35 to 55 form a critical transition period. During this period, many women face a triple challenge: declining fertility, bothersome perimenopausal symptoms, and delayed or delays in recognizing or confirming menopause.

1 Oct 2026

Real-world data reveals higher reported GLP-1 side effects in female patients

The second of a Series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to use of GLP-1 RA drug use in women.

1 Oct 2026

GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health shows that, following a review and meta-analysis of available studies, use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs for diabetes and weight management in women living with diabetes is not associated with adverse pregnancy outcomes in most cases.

1 Oct 2026

New antibiotic combinations aim to prevent recurrent bacterial vaginosis

Researchers and clinicians from Monash University and Bayside Health's Melbourne Sexual Health Centre are trialing new combinations of antibiotics to treat persistent bacterial vaginosis (BV), following their landmark discovery that the condition is sexually transmissible.

30 Sep 2026

Menstrual tracking apps lack evidence of health and performance benefits

Digital menstrual tracking risks creating more harm than benefit and requires greater scrutiny, warn experts in The BMJ today.

30 Sep 2026

Wearable AI forecasts prolonged sitting in women with chronic pelvic pain disorders

Researchers at the Icahn School of Medicine at Mount Sinai have developed an artificial intelligence (AI) approach using data from wearable devices that can forecast upcoming periods of prolonged sitting in women with chronic pelvic pain disorders.

30 Sep 2026

UF professor wins federal grant to develop technology for detecting early-stage endometriosis

Armed with a prestigious federal grant, University of Florida engineering professor Laura Kim, Ph.D., and her research team will develop technology to detect early-stage endometriosis.

22 Sep 2026

BD² awards millions to study bipolar disorder mood changes

Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) today announced its fourth round of Discovery Research grants, totaling more than $13 million, focused on the biological mechanisms of intense mood changes, a hallmark of bipolar disorder.

22 Sep 2026

New spin-out launches technology to revolutionize hormone disorder diagnosis

The University of Birmingham and Imperial College London have announced the launch of Intelligent Mass Spec Solutions Ltd (IMS Solutions), a new spin-out that is set to revolutionize diagnosis of conditions featuring disordered steroid hormone metabolism.

22 Sep 2026

Simple test could take the pain out of womb cancer check

A new test to identify cells collected from urine and vaginal fluid could help rule out womb and other cancers in most women who experience bleeding after the menopause, find University of Manchester researchers.

22 Sep 2026

Common medications trigger potentially harmful prescribing cascades in older adults

A new Ontario-wide study reveals that common medications, from statins to iron supplements, are quietly setting off prescribing cascades that leave older adults unknowingly taking drugs to treat side effects of other drugs.

10 Sep 2026

Menopause documented far less often in electronic health records

Menopause is frequently missing from women's electronic health records, according to a University of Colorado Anschutz study of nearly 396,000 women participating in the National Institutes of Health's All of Us Research Program.

8 Sep 2026

Hormone therapy during menopause transition associated with lower heart disease risk

A study led by Virginia Commonwealth University and the University of Pittsburgh provides pivotal insights into one of the most debated questions in women's health: how does hormone therapy for menopause symptoms affect cardiovascular disease risk when used in peri- or early postmenopause?

8 Sep 2026